These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23708175)

  • 21. Implantable cardiac device procedures in older patients: use and in-hospital outcomes.
    Swindle JP; Rich MW; McCann P; Burroughs TE; Hauptman PJ
    Arch Intern Med; 2010 Apr; 170(7):631-7. PubMed ID: 20386008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and financial impact of implantable cardioverter-defibrillator patients without interventions 5 years after implantation.
    Reichlin T; Kühne M; Sticherling C; Osswald S; Schaer B
    QJM; 2011 Oct; 104(10):849-57. PubMed ID: 21624895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost advantage of dual-chamber versus single-chamber cardioverter-defibrillator implantation.
    Goldberger Z; Elbel B; McPherson CA; Paltiel AD; Lampert R
    J Am Coll Cardiol; 2005 Sep; 46(5):850-7. PubMed ID: 16139136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing sudden death: implantable cardioverter-defibrillators in elderly cardiac patients.
    Groeneveld PW
    LDI Issue Brief; 2008; 13(6):1-4. PubMed ID: 18613344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Comparison of ICD implantations in the United States versus Italy.
    Greenberg SM; Epstein AE; Deering T; Goldman DS; Ghidina M; Neason C; Proclemer A
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S143-6. PubMed ID: 17302692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute lead dislodgements and in-hospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry.
    Cheng A; Wang Y; Curtis JP; Varosy PD
    J Am Coll Cardiol; 2010 Nov; 56(20):1651-6. PubMed ID: 21050975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit.
    Parkash R; Sapp JL; Basta M; Doucette S; Thompson K; Gardner M; Gray C; Brownell B; Kidwai H; Cox J
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):706-13. PubMed ID: 22685111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score.
    van Rees JB; Borleffs CJ; van Welsenes GH; van der Velde ET; Bax JJ; van Erven L; Putter H; van der Bom JG; Schalij MJ
    Heart; 2012 Jun; 98(11):872-7. PubMed ID: 22581736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of early discharge after implantable cardioverter-defibrillator procedures.
    Choudhuri I; Desai D; Walburg J; August P; Keller SI; Suri R
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1123-9. PubMed ID: 22882572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data.
    Pathmanathan RK; Lau EW; Cooper J; Newton L; Skehan JD; Garratt CJ; Griffith MJ
    Heart; 1998 Jul; 80(1):68-70. PubMed ID: 9764063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of implantable cardioverter defibrillators in the New Zealand context from 2000 to 2007.
    Larsen PD; De Silva P; Harding SA; Woodcock E; Lever NA
    N Z Med J; 2010 Feb; 123(1309):76-85. PubMed ID: 20186244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07.
    Proclemer A; Ghidina M; Gregori D; Facchin D; Rebellato L; Fioretti P; Brignole M
    Europace; 2009 Apr; 11(4):465-75. PubMed ID: 19136490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procedure timing as a predictor of inhospital adverse outcomes from implantable cardioverter-defibrillator implantation: insights from the National Cardiovascular Data Registry.
    Hsu JC; Varosy PD; Parzynski CS; Chaudhry SI; Dewland TA; Curtis JP; Marcus GM
    Am Heart J; 2015 Jan; 169(1):45-52.e3. PubMed ID: 25497247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of implantable cardioverter-defibrillators.
    Sanders GD; Hlatky MA; Owens DK
    N Engl J Med; 2005 Oct; 353(14):1471-80. PubMed ID: 16207849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association Between Industry Payments to Physicians and Device Selection in ICD Implantation.
    Annapureddy AR; Henien S; Wang Y; Minges KE; Ross JS; Spatz ES; Desai NR; Peterson PN; Masoudi FA; Curtis JP
    JAMA; 2020 Nov; 324(17):1755-1764. PubMed ID: 33141208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophysiology studies in patients undergoing ICD implantation: findings from the NCDR®.
    Cheng A; Wang Y; Berger RD; Calkins H; Buxton AE; Curtis JP; Lampert R
    Pacing Clin Electrophysiol; 2012 Aug; 35(8):912-8. PubMed ID: 22670627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries.
    Al-Khatib SM; Lucas FL; Jollis JG; Malenka DJ; Wennberg DE
    J Am Coll Cardiol; 2005 Oct; 46(8):1536-40. PubMed ID: 16226180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database.
    MacFadden DR; Crystal E; Krahn AD; Mangat I; Healey JS; Dorian P; Birnie D; Simpson CS; Khaykin Y; Pinter A; Nanthakumar K; Calzavara AJ; Austin PC; Tu JV; Lee DS
    Ann Intern Med; 2012 Feb; 156(3):195-203. PubMed ID: 22312139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Spanish implantable cardioverter-defibrillator registry. First official report of the spanish society of cardiology working group on implantable cardioverter-defibrillators (2002-2004)].
    Peinado R; Arenal A; Arribas F; Torrecilla E; Alvarez M; Ormaetxe JM; Pérez-Castellano N
    Rev Esp Cardiol; 2005 Dec; 58(12):1435-49. PubMed ID: 16371203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation.
    Haines DE; Wang Y; Curtis J
    Circulation; 2011 May; 123(19):2069-76. PubMed ID: 21537001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.